Browsing "Medicine publications" by Author Lee, E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 4 to 8 of 8 < previous 
PreviewIssue DateTitleAuthor(s)
2015Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient miceLee, E.; Yee, D.; Busfield, S.; McManus, J.; Cummings, N.; Vairo, G.; Wei, A.; Ramshaw, H.; Powell, J.; Lopez, A.; Lewis, I.; McCall, M.; Lock, R.
2009Monoclonal antibody-mediated targeting of CD123, IL-3 receptor α chain, eliminates human acute myeloid leukemic stem cellsJin, L.; Lee, E.; Ramshaw, H.; Busfield, S.; Peoppl, A.; Wilkinson, L.; Guthridge, M.; Thomas, D.; Barry, E.; Boyd, A.; Gearing, D.; Vairo, G.; Lopez, A.; Dick, J.; Lock, R.
2021Reduced gonadotrophin receptor expression is associated with a more aggressive ovarian cancer phenotypeCheung, J.; Lokman, N.A.; Abraham, R.D.; Macpherson, A.M.; Lee, E.; Grutzner, F.; Ghinea, N.; Oehler, M.K.; Ricciardelli, C.
2013Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcriptionThomas, D.; Powell, J.; Vergez, F.; Segal, D.; Nguyen, N.; Baker, A.; Teh, T.; Barry, E.; Sarry, J.; Lee, E.; Nero, T.; Jabbour, A.; Giovanna, P.; Green, B.; Manenti, S.; Glaser, S.; Parker, M.; Lopez, A.; Ekert, P.; Lock, R.; et al.
2014Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCCBusfield, S.; Biondo, M.; Wong, M.; Ramshaw, H.; Lee, E.; Ghosh, S.; Braley, H.; Panousis, C.; Roberts, A.; He, S.; Thomas, D.; Fabri, L.; Vairo, G.; Lock, R.; Lopez, A.; Nash, A.